Connor, Clark & Lunn Investment Management Ltd. Cogent Biosciences, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$4.06 - $10.08 $577,689 - $1.43 Million	-142,288 Reduced 62.99%	83,600 $491,000
Q3 2023 Nov 13, 2023	SELL	$9.69 - $13.34 $486,379 - $669,587	-50,194 Reduced 18.18%	225,888 $2.2 Million
Q2 2023 Aug 10, 2023	BUY	$9.85 - $13.24 $11,494 - $15,451	1,167 Added 0.42%	276,082 $3.27 Million
Q1 2023 May 09, 2023	BUY	$10.04 - $15.5 $19,387 - $29,930	1,931 Added 0.71%	274,915 $2.97 Million
Q4 2022 Feb 10, 2023	BUY	$10.65 - $14.84 $135,137 - $188,304	12,689 Added 4.87%	272,984 $3.16 Million
Q3 2022 Nov 10, 2022	BUY	$9.39 - $16.99 $808,356 - $1.46 Million	86,087 Added 49.42%	260,295 $3.88 Million
Q2 2022 Aug 05, 2022	BUY	$3.92 - $9.73 $682,895 - $1.7 Million	174,208 New	174,208 $1.57 Million

Others Institutions Holding COGT

# of Institutions

172

Shares Held

114M

Call Options Held

56.7K

Put Options Held

40.4K

Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

10.5M
Shares

$97.5 Million
0.31% of portfolio
Kynam Capital Management, LP Princeton, NJ

9.24M
Shares

$86 Million
8.19% of portfolio
Commodore Capital LP New York, NY

7.54M
Shares

$70.2 Million
6.92% of portfolio
Black Rock Inc. New York, NY

7.29M
Shares

$67.9 Million
0.0% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

6.96M
Shares

$64.8 Million
9.76% of portfolio

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $612M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account